2425 55th Street, Suite 210 Boulder, CO 80301 303-420-4420

Recent Posts by admbbt

Bolder BioTechnology Receives Two U.S. Patents for Second Generation Hematopoietic Factors

Boulder, Colorado - July 16, 2007 - Bolder BioTechnology, Inc. is pleased to announce that it has been granted patents 7,214,779 and 7,232,885 by the U.S. Patent and Trademark Office. Joe Cox, Company President commented "These patents broaden the scope of intellectual property protection for our long-acting, second generation granulocyte-macrophage colony-stimulating factor (GM-CSF) analog and granulocyte…
Read more

Bolder BioTechnology Receives Two U.S. Patents for Long-Acting GM-CSF Analogs

Boulder, Colorado - January 2, 2007 - Bolder BioTechnology, Inc. is pleased to announce that it has been granted patents 7,148,333 and 7,153,943 by the United States Patent and Trademark Office. Joe Cox, Company President said "These patents provide important intellectual property protection for our long-acting granulocyte-macrophage colony-stimulating factor (GM-CSF) analogs. GM-CSF is a human protein…
Read more

The National Cancer Institute Awards Bolder BioTechnology a Phase II SBIR Grant to Continue Development of Novel Anti-Cancer Compound

Boulder, Colorado - November 10, 2006 - Bolder BioTechnology, Inc. today announced that it has been awarded a $775,848 Phase II Small Business Innovation Research (SBIR) grant from the National Cancer Institute of The National Institutes of Health (NIH). The grant will be used to perform preclinical efficacy and pharmacology studies of the company's proprietary long-acting…
Read more

Bolder BioTechnology Relocates Laboratory Facility to Boulder, Colorado

Boulder, Colorado – March 3, 2006 - Bolder BioTechnology, Inc. is pleased to announce that it has relocated its research operations and corporate headquarters to 2945 Wilderness Place, Suite 100, Boulder, Colorado 80301. The Boulder facility includes approximately 8,500 square feet of laboratory and office space. CRESA Partners of Denver, Colorado provided brokerage services and advised…
Read more

Recent Comments by admbbt

No comments by admbbt yet.